Comorbidities and subgroups of patients surviving severe acute hypercapnic respiratory failure in the intensive care unit

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 2, 2017, Pages 200-207

  Adler, Dan ^a,c   Peṕin, Jean Louis ^b   Dupuis Lozeron, Elise ^a,c   Espa Cervena, Katerina ^a   Merlet Violet, Roselyne ^c   Muller, Hajo ^c   Janssens, Jean Paul ^a   Brochard, Laurent ^d,e  

^a Division of Pulmonary Diseases   (France)

^b UNIV GRENOBLE ALPES   (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute hypercapnic respiratory failure; COPD; Intensive care

Indexed keywords

AGED; APNEA HYPOPNEA INDEX; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HYPERCAPNIA; HYPERTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MULTIPLE CHRONIC CONDITIONS; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDUAL VOLUME; RESPIRATORY FAILURE; SLEEP; SLEEP DISORDERED BREATHING; SURVIVAL; TOTAL LUNG CAPACITY; TRANSTHORACIC ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEART; HEART DISEASES; LUNG; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; SURVIVOR; SWITZERLAND;

AGED; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS; LUNG; MALE; PATIENT READMISSION; POLYSOMNOGRAPHY; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; SLEEP APNEA, OBSTRUCTIVE; SURVIVORS; SWITZERLAND;

EID: 85025126139     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201608-1666OC     Document Type: Article

References (37)

1. Carrillo A, Ferrer M, Gonzalez-Diaz G, Lopez-Martinez A, Llamas N, Alcazar M, Capilla L, Torres A. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:1279-1285.
2. Chu C-M, Chan VL, Lin AWN, Wong IWY, Leung W-S, Lai CKW. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004:59;1020-1025.
3. Adler D, Dupuis-Lozeron E, Richard J-C, Janssens J-P, Brochard L. Does inspiratory muscle dysfunction predict readmission after intensive care unit discharge?. Am J Respir Crit Care Med 2014;190:347-350.
4. Rennard SI, Locantore N, Delafont B, Tal-Singer R, Silverman EK, Vestbo J, Miller BE, Bakke P, Celli B, Calverley PMA, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc 2015;12:303-312.
5. Struik FM, Sprooten RTM, Kerstjens HAM, Bladder G, Zijnen M, Asin J, Cobben NAM, Vonk JM, Wijkstra PJ. Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: A randomised, controlled, parallel-group study. Thorax 2014;69:826-834.
6. Borel J-C, Pépin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, Timsit J-F. Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients. Respirology 2014;19:857-865.
7. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome. Am J Respir Crit Care Med 2010; 182:325-331.
8. O'Donoghue FJ, Howard ME. Obesity, COPD, NIV and reverse epidemiology. Respirology 2014;19:777-779.
9. Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, Taylor MRG, Zwillich CW. Obesity-associated hypoventilation in hospitalized patients: Prevalence, effects, and outcome. Am J Med 2004;116:1-7.
10. Budweiser S, Hitzl AP, Jörres RA, Schmidbauer K, Heinemann F, Pfeifer M. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: A prospective survival analysis. Respir Res 2007;8:92.
11. Pérez de Llano LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vázquez Caruncho M, Caballero Muinelos O, Alvarez Carro C. Shortterm and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005;128:587-594.
12. Priou P, Hamel JF, Person C, Meslier N, Racineux JL, Urban T, Gagnadoux F. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest 2010;138: 84-90.
13. Borel J-C, Burel B, Tamisier R, Dias-Domingos S, Baguet J-P, Levy P, Pépin JL. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. PLoS One 2013;8:e52006.
14. Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and allcause mortality: A decade-long historical cohort study. PLoS Med 2014;11:e1001599.
15. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, et al.; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-161.
16. Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, van Empel VPM, Bruijnzeel PLB, Rutten EPA, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-735.
17. Vanfleteren LEGW, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir Med 2016;4:911-924.
18. Pacilli AMG, Valentini I, Carbonara P, Marchetti A, Nava S. Determinants of noninvasive ventilation outcomes during an episode of acute hypercapnic respiratory failure in chronic obstructive pulmonary disease: The effects of comorbidities and causes of respiratory failure. Biomed Res Int 2014;2014:976783.
19. Scala R, Bartolucci S, Naldi M, Rossi M, Elliott MW. Co-morbidity and acute decompensations of COPD requiring non-invasive positivepressure ventilation. Intensive Care Med 2004;30:1747-1754.
20. Triest FJJ, Franssen FME, Spruit MA, Groenen MTJ, Wouters EFM, Vanfleteren LEGW. Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur Respir J 2015;46: 1492-1495.
21. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
22. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, et al.; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
23. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiography 2009;22:107-133.
24. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.; ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
25. Kohler M, Stoewhas A-C, Ayers L, Senn O, Bloch KE, Russi EW, Stradling JR. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: A randomized controlled trial. Am J Respir Crit Care Med 2011;184: 1192-1199.
26. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, et al. Rules for scoring respiratory events in sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Clin Sleep Med 2012;8:597-619.
27. Buuren SV, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw 2011;45:1-67.
28. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 2004.
29. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2794-2800.
30. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax 2010;65:956-962.
31. MacDonald MI, Shafuddin E, King PT, Chang CL, Bardin PG, Hancox RJ. Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med 2016;4:138-148.
32. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-1014.
33. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, et al. Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study. Lancet Respir Med 2015;3:310-318.
34. Glaser JB, El-Haddad H. Exploring novel Medicare readmission risk variables in chronic obstructive pulmonary disease patients at high risk of readmission within 30 days of hospital discharge. Ann Am Thorac Soc 2015;12:1288-1293.
35. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJV. Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009;11:130-139.
36. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39:51-58.
37. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XHT, Deswal A. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012;59:998-1005.